DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 27 May · 21:39 IST

Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹1320.00
prior close
₹1318.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.0-0.7-2.5-3.3-4.4-3.9-2.8-3.8-4.0+4.5
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories has published a notice informing shareholders about unclaimed dividends from financial year 2018-19 that are liable to be transferred to the Investor Education and Protection Fund (IEPF). The company has sent individual notices to shareholders whose dividends remain unpaid for 7 consecutive years. Shareholders have until August 30, 2026 to claim their unpaid dividends by contacting the company's Registrar (Bigshare Services) or the Company Secretary. If no valid claim is made by this deadline, the shares will be transferred to the IEPF Authority. Details of affected shareholders are available on the company's website.

Likely market impact

This is a routine regulatory compliance filing with no direct impact on stock price or company operations. Affected shareholders risk losing their unclaimed dividends and shares if they fail to claim them before the August 30, 2026 deadline.